|
ZNF280C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.240300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.370300E-02 |
| Normal-vs-Stage2 |
1.996370E-01 |
| Normal-vs-Stage3 |
5.268400E-01 |
| Normal-vs-Stage4 |
1.562960E-01 |
| Stage1-vs-Stage2 |
9.694800E-01 |
| Stage1-vs-Stage3 |
1.558020E-01 |
| Stage1-vs-Stage4 |
9.834400E-01 |
| Stage2-vs-Stage3 |
3.957000E-01 |
| Stage2-vs-Stage4 |
9.633400E-01 |
| Stage3-vs-Stage4 |
3.567000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.045600E-02 |
| Normal-vs-AfricanAmerican |
6.961800E-01 |
| Normal-vs-Asian |
1.277680E-03 |
| Caucasian-vs-AfricanAmerican |
3.218600E-01 |
| Caucasian-vs-Asian |
4.346200E-02 |
| AfricanAmerican-vs-Asian |
1.042480E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.872500E-02 |
| Normal-vs-Female |
5.202100E-02 |
| Male-vs-Female |
6.730800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.795630E-01 |
| Normal-vs-Age(41-60Yrs) |
2.150200E-02 |
| Normal-vs-Age(61-80Yrs) |
1.981030E-01 |
| Normal-vs-Age(81-100Yrs) |
9.951800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.407000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.711400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.227000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.765040E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.620200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.907400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.915400E-03 |
| Normal-vs-Grade 2 |
1.090360E-02 |
| Normal-vs-Grade 3 |
4.535200E-01 |
| Normal-vs-Grade 4 |
2.945800E-01 |
| Grade 1-vs-Grade 2 |
3.097400E-01 |
| Grade 1-vs-Grade 3 |
3.343800E-02 |
| Grade 1-vs-Grade 4 |
2.505200E-01 |
| Grade 2-vs-Grade 3 |
2.472300E-02 |
| Grade 2-vs-Grade 4 |
4.457400E-01 |
| Grade 3-vs-Grade 4 |
5.499600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.984300E-03 |
| Normal-vs-ccB subtype |
1.622810E-01 |
| ccA subtype-vs-ccB subtype |
2.362800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.562400E-02 |
| Normal-vs-N1 |
9.161800E-01 |
| N0-vs-N1 |
3.463000E-01 |
|
|
